Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;75(7):3658-64.
doi: 10.1128/IAI.00244-07. Epub 2007 May 14.

Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin

Bo Wu  1 , Chunhong Huang, Lourdes Garcia, Alfredo Ponce de Leon, Jose Sifuentes Osornio, Miriam Bobadilla-del-Valle, Leticia Ferreira, Sergio Canizales, Peter Small, Midori Kato-Maeda, Alan M Krensky, Carol Clayberger
Affiliations

Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin

Bo Wu et al. Infect Immun. 2007 Jul.

Abstract

Vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) has variable efficacy in preventing tuberculosis. We hypothesized that some of this variation might be due to differences among BCG strains. To test this, neonates in Orizaba, Mexico, were vaccinated with one of three different BCG strains (BCG-Brazil [BBCG], BCG-Denmark [DBCG], or BCG-Japan [JBCG]). One year after vaccination, peripheral blood mononuclear cells (PBMC) were obtained and recall immune responses to culture filtrate proteins (CFP) of Mycobacterium tuberculosis were evaluated using quantitative real-time PCR. CFP-activated PBMC from BBCG- and DBCG-immunized children expressed high levels of cytokines characteristic of an adaptive immune response (gamma interferon, interleukin-2beta [IL-12beta], and IL-27), while those from children immunized with JBCG did not. In contrast, vaccination with JBCG resulted in significantly greater expression of cytokines characteristic of a proinflammatory immune response (IL-1alpha, IL-1beta, IL-6, and IL-24) in PBMC activated with CFP compared to PBMC from children vaccinated with BBCG or DBCG. Thus, different strains of BCG can activate different immune pathways, which may affect long-term vaccine efficacy.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Expression of IFN-γ, IL-12β, and IL-27 mRNA in PBMC from infants vaccinated with BBCG, DBCG, or JBCG. Median increases are represented by horizontal bars.
FIG. 2.
FIG. 2.
Expression of IL-1α, IL-1β, IL-6, and IL-24 in PBMC from infants vaccinated with BBCG, DBCG, or JBCG. Median increases are represented by horizontal bars.
FIG. 3.
FIG. 3.
Expression of FOXP3, IL-2, IL-5, IL-8, IL-9, IL-10, IL-12α, IL-23α, TGF-β1, and TNF-α in PBMC from infants vaccinated with BBCG, DBCG, or JBCG. Median increases are represented by horizontal bars.
FIG. 4.
FIG. 4.
Hierarchical clustering of expression of IFN-γ, IL-27, IL-12β, IL-1α, IL-1β, IL-24, and IL-6. The color intensity reflects the magnitude of high (red rectangle) or low (blue rectangle) mRNA expression. Each row represents the mRNA expression profile of one infant, and each column represents one cytokine. (A) Hierarchical clustering of mRNA expression. Cytokines with similar immune functions are grouped. (B) Distribution of high and low responders among BCG-vaccinated infants. The chi-square test was performed (P > 0.05). (C) Cytokine responses in high responders among BBCG- or DBCG-vaccinated and JBCG-vaccinated infants. Type I, IL-1α/IL-1β/IL-24/IL-6; type II, IFN-γ/IL-27/IL-12β; type III, IFN-γ/IL-27/IL-12β/IL-1α/IL-1β/IL-24/IL-6. Fisher's exact test was performed (P < 0.0001).
See this image and copyright information in PMC

References

    1. Algood, H. M., and J. L. Flynn. 2004. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173:3287-3296. - PubMed
    1. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511. - PubMed
    1. Bhatt, K., S. P. Hickman, and P. Salgame. 2004. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 172:2748-2751. - PubMed
    1. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, K. Branson, S. D. Chaguluka, L. Donovan, E. Jarman, E. King, P. E. Fine, and H. M. Dockrell. 2002. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401. - PubMed
    1. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Investig. 105:1317-1325. - PMC - PubMed

Publication types

MeSH terms